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The Scientific Program will focus on the most im-
portant topics of cancer research. There will be plenary 
lectures and round-table-discussions by experts in the 
field as well as carefully selected oral presentations and 
scientific posters. Confirmed Speakers of the Confe-
rence: Vladimir Bogatyrev, N.N. Blokhin Russian Cancer 
Research Center of the Russian Academy of Medical 
Sciences, Moskow, Russia; Friederike Berberich-Siebelt, 
Department of Molecular Pathology and Neurology, Julius 
Maximilians-University Wuerzburg, Germany; Vasyl F. 
Chekhun, R.E. Kavetsky Institute of Experimental Pathol-
ogy, Oncology and Radiobiology, Kyiv, Ukraine; Ludmila 
Drobot, Palladin Institute of Biochemistry, NAS of Ukraine, 
Kyiv, Ukraine; Alexander Eggermont, Department of Sur-
gical Oncology, Erasmus University, Rotterdam, Nether-
lands; Helmut Friess, Department of Surgery, Technische 
Universität München, Munich, Germany; Danilo F. Gluz-
man, Professor, R.E. Kavetsky Institute of Experimental 
Pathology, Oncology and Radiobiology, Kyiv, Ukraine; 
Ivan Gout, Cancer Biochemistry UCL Research Depart-
ment of Structural and molecular biology University Col-
lege London, UK; Michael Horsman, Department of Ex-
perimental Clinical Oncology, Aarhus University Hospital 
Aarhus, Denmark; Peter A. Jones, University of Southern 
California/Norris Comprehensive Cancer Center, Los 
Angeles, CA, USA; Jörg Kleeff, Department of Surgery, 
Technische Universität München, Munich, Germany; Eva 
Klein, Microbiology and Tumor Biology Center of Karo-
linska Institute, Stockholm, Sweden; Michael Molls, De-
partment of Radiation Oncology, Technische Universität 
München, Munich, Germany; Vladimir M. Moiseenko, 
Petrov Institute of Oncology, St. Petersburg, Russia; 
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Dear colleagues,
On behalf of the Organizing Committee, it is a great honor to welcome you to attend 
the International Conference “Tumor and Host: Novel Aspects of Old Problem” 
devoted to the 50th anniversary of R.E. Kavetsky Institute of Experimental Pathology, 
Oncology and Radiobiology of National Academy of Sciences of Ukraine (T&H-2010) 
which will be held during September 21–24, 2010. The 50th anniversary will be ce-
lebrated in the wonderful city of Kyiv, Ukraine — one of the oldest European Capitals 
with its 1500 year rich history, nation’s financial, political and cultural centre.
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology is 
leading cancer research centre in Ukraine, associated member of the Organization of European Cancer Insti-
tutes and European Association for Cancer Research.
The mission of this conference is to advance the understanding of mechanisms of cancer development, 
tumor and host interaction and outline new strategies for cancer prevention and treatment. The Scientific 
Program will cover the most important topics of cancer research and will be divided into 5 Sessions: 1) Tumor 
biology and Immunology; 2) Metabolic and Stromal Microenvironment of Tumor Cells; 3) Tumor markers: Sig-
naling, Diagnosis and Prognosis; 4) Mechanism of Tumorigenesis and Cancer Prevention; 5) Cancer Therapy: 
New Technologies, Biotherapy, Individualization. An outstanding panel of speakers will lead and facilitate the 
discussions on and around new diagnostics, therapies, biomarkers, latest trends and developments in tumor 
and host interactions. In addition to the scientific program, you will be able to enjoy the culture and sights of 
Kyiv, one of the largest and the most inspirational cities in Ukraine and Slavic World.
The Conference sessions will be held in the Conference Hall of the National Academy of Sciences of Ukraine 
located in the historic centre of Kyiv. The Official Opening Ceremony and Keynote Forum will take place on 
Tuesday afternoon, September 21. We would be honored by your attendance of the Conference, we hope that 
you will enjoy this opportunity to communicate with colleagues from all over the world. All Ukrainian scientific 
community cordially welcome you to join us in Kyiv.
Professor Vasyl F. Chekhun
Chairman of the Organizing Committee of T&H-2010
Director of R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology of National Academy of Sciences of Ukraine
Academician of National Academy of Sciences of Ukraine
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Sergiy P. Osinsky, R.E. Kavetsky Institute of Experimental 
Pathology, Oncology and Radiobiology, Kyiv, Ukraine; 
Semyon V. Petrov, Department of pathology, Kazan State 
Medical University, Kazan, Russia; Ihor Pogribniy, Na-
tional Center of Toxicological Research, Jefferson, USA; 
Sharon A. Ross, National Cancer Institute, Bethesda, 
USA; Ivan Rusyn, University of North Carolina, Chapel 
Hill, USA; Alexander M. Shneider, Cure Lab Inc. Canton, 
USA; Antonio Sica, Istituto Clinico Humanitas, Milan, Italy; 
Galina I. Solanik, R.E. Kavetsky Institute of Experimental 
Pathology, Oncology and Radiobiology, Kyiv, Ukraine; 
Peter Vaupel, University Mainz, University Medical Center, 
Mainz, Germany; Robert A. Weinberg, Whitehead Institute 
for Biomedical Research and Department of Biology Mas-
sachusetts Institute of Technology, Cambridge, USA; Isaac 
Witz, Tel Aviv University, Tel Aviv, Israel..
SESSION 1: 
TUMOR BIOLOGY AND IMMUNOLOGY
Chair: Dr. Eva Klein, Professor, Microbiology and 
Tumor Biology Center of Karolinska Institute, Stock-
holm, Sweden.
Co-Chair: Dr. Juriy I. Kudravets, Professor, R.E. Ka-
vetsky Institute of Experimental Pathology, Oncology 
and Radiobiology, Kyiv, Ukraine.
The session will focus on the basic aspects of tumor 
biology and immunology in a single issue framework. 
Topics include mechanisms that determine metasta-
sis and homing of tumor cells, tumor angiogenesis 
and lymphoangiogenesis, the biology and molecular 
biolo gy of cancer stem cells, immunological aspects 
of tumor-host interaction.
SESSION 2: 
METABOLIC AND STROMAL 
MICROENVIRONMENT OF TUMOR CELLS
Chair: Dr. Peter Vaupel, Professor, University 
Mainz, University Medical Center, Germany.
Co-Chair: Dr. Sergiy P. Osinsky, Professor, 
R.E. Kavetsky Institute of Experimental Pathology, 
Oncology and Radiobiology, Kyiv, Ukraine.
The session will focus on the tumor microenvi-
ronment as a key factor in tumor development and 
progression. Topics include hypoxia signaling, angio-
genesis and aerobic glycolysis in human tumors as a 
basis for diagnostics and anticancer strategies. Key 
questions which are to be discussed: 1) Inflammation 
and cancer: what is common and what is different? 
2) Tumor hypoxia impact on tumor-host interaction: 
a main regulator of malignant process outcome?
SESSION 3: 
TUMOR MARKERS: SIGNALING, 
DIAGNOSIS AND PROGNOSIS
Chair: Dr. Danilo F. Gluzman, Professor, R.E. Ka-
vetsky Institute of Experimental Pathology, Oncology 
and Radiobiology, Kyiv, Ukraine.
Co-Chair: Dr. Ivan Gout, Professor, Cancer Bio-
chemistry UCL Research Department of Structural 
and molecular biology University College, London, UK;
Co-Chair: Dr. Svitlana P. Sidorenko, R.E. Kavetsky 
Institute of Experimental Pathology, Oncology and 
Radiobiology, Kyiv, Ukraine.
The session will cover fundamental and practical 
aspects of tumor markers: identification of novel tumor 
markers, peculiarity of signal transduction pathways 
in tumor cells, application of tumor markers and cell dif-
ferentiation antigens for cancer diagnosis and prognosis.
SESSION 4: 
MECHANISM OF TUMORIGENESIS AND 
CANCER PREVENTION
Chair: Dr. Ihor Pogribniy, Professor, Division of Bio-
chemical Toxicology, National Center for Toxicological 
Research, Jefferson, AR, USA.
Co-Chair: Dr. Peter A. Jones, Professor, University 
of Southern California/Norris Comprehensive Cancer 
Center, Los Angeles, CA, USA.
The session will focus on mechanisms of tumori-
genesis and cancer prevention research through early 
detection, treatment and lifestyle changes with key 
features on molecular biology and genetics and their 
interactions with clinical cancer prevention.
SESSION 5: 
CANCER THERAPY: NEW TECHNOLOGIES, 
BIOTHERAPY, INDIVIDUALIZATION
Chair: Dr. Volodimir O. Shlahovenko, Professor, 
R.E. Kavetsky Institute of Experimental Pathology, 
Oncology and Radiobiology, Kyiv, Ukraine.
Co-Chair: Dr. Vladimir M. Moiseenko, Professor, 
Petrov Institute of Oncology, St. Petersburg, Russia
Co-Chair: Dr. Galina I. Solanik, R.E. Kavetsky 
Institute of Experimental Pathology, Oncology and 
Radiobiology, Kyiv, Ukraine.
The clinical and experimental investigations of cancer 
therapeutics mediated through tumor-host interactions 
(biotherapy, vascular disruptive therapy, etc.), validation 
of new targets for cancer therapy and new strategies for 
delivering therapy to tumors will be discussed.
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